Pulsed Electromagnetic Fields in the Treatment of Prostatic Hyperplasia
In order to evaluate the effect of the use of pulsed electromagnetic fields on benign prostatic hyperplasia, a randomized, prospective, longitudinal study was performed in 120 patients; with clinical and radiological diagnosis of benign prostatic hyperplasia with moderate symptomatology according to the International Scale of Prostatic Symptoms; who went to the Natural and Traditional Medicine clinic of the Rampa polyclinic, in the period from September 2016 to February 2017. The sample was divided into two groups of 60 patients each: 1) Control: Did not receive any sessions with pulsed electromagnetic fields, only behavior expectant with hygienic dietary indications. 2) 30 sessions of pulsed electromagnetic fields were applied in the perineal area with the patient in a seated position, with a daily frequency. In the two groups, the following variables were evaluated before and after three months of PEMF use: the International Scale of Prostatic Scale (IPSS) scores, the score obtained in the Erectile Dysfunction Questionnaire IIEF-5, the prostate specific antigen (PSA) values and the degree of prostatic hypertrophy in relation to the volume calculated by abdominal ultrasound. When applying the analysis of covariance for comparison of means (ANOVA) p = 5.9 · 10-8, it was found that there was no difference between the groups before they started the sessions, it behaved homogeneously. As a result, the group that used pulsed electromagnetic fields was statistically (p = 0.00) higher than the group that received only expectant management, in the IPSS, in the IPSS quality of life assessment, in the IIEF- 5 and prostate volume. No adverse events were reported in the group that used pulsed electromagnetic fields. It is concluded that the use of pulsed electromagnetic fields in the recovery of benign prostatic hyperplasia with moderate symptomatology according to the International Scale of Prostatic Symptoms is a safe and effective method.